CANCER: CARCINOGENS and CARCINOGENESIS BIOM 255 Drugs and Disease: The pathophysiological and molecular bases of disease and drug therapy March 3, 2009.

Slides:



Advertisements
Similar presentations
Cancer—Principles and overview By Robert A. Weinberg
Advertisements

Early Embryonic Development Maternal effect gene products set the stage by controlling the expression of the first embryonic genes. 1. Transcription factors.
Hepatocellular carcinoma (HCC) is the fifth most frequent cancer in the world and the third most common cause of cancer mortality.
Metastasis. Mechanisms of Invasion and Metastasis.
Etiology Of Cancer &Carcinogenic Agents
Etiology of cancer: Carcinogenic agents
The Cell Cycle and Cancer. Cell signaling: chemical communication between cells. Click on above to go to animation second chemical response inside the.
Acute Myelogenous Leukemia and its Impact on the Immune System
1 Altered Cell Growth and Cancer Development Keith Rischer RN, MA, CEN.
Cancer.
Robert Farley University of Rhode Island Department of Biomedical Engineering.
Cancer Biology. 2 Outline 1.How do cancer cells differ from normal cells? Tumor progression Molecular basis for cancer.
EH 205 FALL 2009 Cancer review session Carlos O. Mendivil-Anaya, MD.
Cancer Cells Gone Wild!. Cancer Cell Surrounded by T-cells and dead.
Characterization of a potential new drug in cancer therapy Lab 2 Salah Farag.
 Primary liver cancer is the fifth most common cancer in the world and the third most common cause of cancer mortality  Hepatocellular carcinomas (HCCs)
Cellular Oncogenes. We made it to the 70s v-src c-src proto-oncogeneoncogene Viral oncogenes paved the way.
Genomics Lecture 7 By Ms. Shumaila Azam. Tumor Tumor – abnormal proliferation of cells that results from uncontrolled, abnormal cell division A tumor.
Viruses and Cancer.
HOW TO CONTROL CANCER Putting Science into Practice.
Neoplasms.
Tumor genetics Minna Thullberg
Tumorigenesis and Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Cancer: when our own cells become the enemy
Cancer:a number of diseases that arise due to genetic alterations in cells that lead to unchecked growth (tumorigenesis). Dietary and immune factors are.
Cancer : A Genetic Disease Drill: 1.Write down 1 thing you know about the disease. 2.What would you most like to learn about cancer / What question would.
CANCER Epidemiology Updated January 2011 Source: Cancer: New Registrations and Deaths retrieved Jan 25 th 2012 from Ministry of Health. May 2011.
3.1.3.A Understanding Cancer What is Cancer.
National Committee for the Certification of Radiation Protection Officer BIOLOGICAL EFFECTS OF IONIZING RADIATION.
Tumorigenesis to Cancer Development Pin Ling ( 凌 斌 ), Ph.D. ext 5632; References: 1.Chapter 23 Cancer in “Molecular Cell Biology”
Copyright © 2006 Pearson Education, Inc. publishing as Benjamin Cummings.
Control of the Cell Cycle. Cyclins Cell cycle is controlled by proteins called cyclins and a set of enzymes that attach to the cyclin and become activated.
Carcinogenesis Carcinogenesis is mostly due to non-lethal genetic damage Such genetic damage (or mutation) may be acquired by the action of environmental.
SC121 Unit Three Karma Pace, MS AIM: kpacemcduffy.
Human Biology Sylvia S. Mader Michael Windelspecht
วัตถุประสงค์ สามารถอธิบาย multi-step tumorigenesis ได้ สามารถอธิบาย multi-step tumorigenesis ได้ สามารถอธิบายบทบาทของ tumor promoter ในการเริ่มต้นการ เกิดมะเร็ง.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Cancer When cell division goes wrong……. Growing out of control, cancer cells produce malignant tumors Cancer is a general term for many diseases in.
Genomics and Me The Study of Cancer Disease. Introduction What is Cancer Disease? A set of disease in which cells escape from the control mechanisms A.
What is Cancer??. Cancer The name for disease(s) in which the body's cells become abnormal and uncontrollably divide.
Dr. Saleem Shaikh NEOPLASIA - II. Majority of the neoplasms are categorised clinically and morphologically into benign and malignant on basis of certain.
Presented by: Dr/Fedaa Abd-Elmonem Clinical pharmacy instructor Tanta University.
Epidemiology 242: Cancer Epidemiology Zuo-Feng Zhang, MD, PhD Fall Quarter, 2009.
Lecture 12: Cancer: a cellular perspective Dr. Mamoun Ahram Faculty of Medicine Second year, Second semester, Principles of Genetics and Molecular.
PHL 472 Chemical Carcinogens Abdelkader Ashour, Ph.D. 2 nd Lecture.
Furan-Induced Cytotoxicity, Cell Proliferation, and Tumorgenicity in Mouse Liver Dr. Glenda Moser.
Inflammation and Cancer
Mitosis & Cancer. What is Cancer? Mutated cells that are not longer under control Cancer Cells Grow uncontrollably Multiply more rapidly than normal cells.
Retroviral oncogenes. Cellular protooncogenes Mutation carrying cells with proliferation advantage Activated protooncogene.
Regulation of the Cell Cycle. How does a cell know when to divide and when not to divide?
Cancer Bioinformatics Tom Doman Bioinformatics Scientist Eli Lilly & Company Informatics 519 guest lecture IU Bloomington Sept
NEOPLASIA(신생물) Neoplasia: “new growth” – An abnormal mass of tissue, overgrowth of cell, uncordinated with that than of normal tissue A. Growth pattern.
La nuova biologia.blu Anatomia e fisiologia dei viventi S
Cancer When good cells go bad.
Cancer progresses through accumulation of multiple mutations
GENETIC BASIS OF CANCER
Carcinogenic Agents.
The Genetic Basis of Cancer
Cancer.
Cancer Etiology علت شناسي سرطانها سرطان به پارسي به معناي چنگار=خرچنگ.
Molecular Basis Of Cancer
Adaptive Response to Low Dose Radiation
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
Volume 29, Issue 4, Pages (April 2016)
Tumor Promotion via Injury- and Death-Induced Inflammation
M.B.Ch.B, MSC, PhD, DCH (UK), MRCPCH
1.6 U.6 Mutagens, oncogenes and metastasis are involved in the development of primary and secondary tumours. Tumours are abnormal growth of tissue that.
Presentation transcript:

CANCER: CARCINOGENS and CARCINOGENESIS BIOM 255 Drugs and Disease: The pathophysiological and molecular bases of disease and drug therapy March 3, 2009 Hyam Leffert, MD

OVERVIEW Agents (molecules, radiation or viruses) that cause cancer are called carcinogens. This causal process is called carcinogenesis. In humans, it is generally accepted that most epithelial cancers are caused by environmental exposure to certain kinds of chemicals. However, carcinogenesis is clearly influenced by large numbers of genes and non-carcinogenic environmental factors (notably diet, and underlying inflammation). This discussion will review basic principles of cancer and chemical carcinogenesis, focusing upon hepatocarcinogenesis as a model system. We will also consider two outstanding questions: 1. What molecular events are thought to be critical for carcinogenesis? 2. What carcinogen-targeted cells give rise to cancer? References 1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell Jan 7;100(1): [Assigned reading] 2. Balmain A, Harris CC. Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis Mar;21(3): Vogelstein B, Kinzler KW. Cancer genes and the pathways they control. Nature Med. 2004; 10(8): Luch A. Nature and nurture - lessons from chemical carcinogenesis. Nat Rev Cancer Feb;5(2): [Assigned reading] 5. Li HC, Stoicov C, Rogers AB, Houghton J. Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol Jan 21;12(3): Weinberg RA. The Biology of Cancer Garland Science, New York, NY (This recently published textbook and accompanying CD-R is in the SOM LIBRARY RESERVE)

BASIC PRINCIPLES

WHAT DO CANCERS LOOK LIKE? Cancerous tissues and metastatic cancer cells (that migrate away from primary sites) display disorganized arrays of normal macroscopic and microscopic tissue structure.

Hepatocellular Carcinoma ( Ovarian Carcinoma (from BIOM 255 lecture of S. Howell, MD) Acute Myelogenous Leukemia (Bone Marrow) ( Breast Carcinoma (Inflammatory) (

PROPERTIES OF CANCER CELLS (diagram is from Reference #1)

THOUSANDS OF KNOWN CARCINOGENIC AGENTS ARE IN THE ENVIRONMENT Organic molecules (PAHs, aromatic amines) Inorganic molecules (vinyl chloride) Heavy metals (lead, arsenic, chromium[VI]) Viruses (HBV, HCV, HPV, HIV) Radiation (gamma, X-ray, high energy beta) Inert substances (asbetos) (See Reference #2, and Reference #4 for Summary Table)

CARCINOGENESIS INVOLVES 2 STEPS 1.INITIATION (“initiators”) -Rapid -Usually requires metabolic activation (procarcinogen  carcinogen) -Sufficient to induce carcinogenesis if exposure dose is high enough (controversial) -Precedes promotion -May cause mutations or epigenetic changes 2. PROMOTION (“promoters”) -Follows initiation -Long period of time -Augments effects of low dose initiator -Associated with increased survival and/or clonal expansion of initiated clones

METABOLIC ACTIVATION REQUIRES SPECIALIZED ENZYMES: e.g. CYP450s (receptors, co-factors and many other enzymes are also involved) (diagram is from Reference #4)

PROPOSED CARCINOGENIC EVENTS Genotoxic and non-genotoxic effects of carcinogens (diagram is from Reference #4)

PROPOSED CARCINOGENIC PATHWAYS (diagram is from Reference #1; see also Reference #3)

LIVER CANCER

Diagram of the HEPATIC LOBULE

HEPATOCARCINOGENESIS Hepatocellular carcinomas (‘HCC’, parenchymal cell-like) are the most frequent type of liver cancer. Millions of people world-wide are diagnosed yearly with HCC, mostly in Southeast Asia and Africa. High mortality rates with widespread metastasis (preference for lung). Gender preference due to endocrine status (male >> female). HCC is strongly associated with viral (HBV, HCV), chemical (aflatoxin-B 1 ) and dietary exposures (alcohol). Inflammation may act as a promoter of HCC. Non-HCC hepatic angiosarcomas are caused by exposure to vinyl chloride.

Diethylnitrosamine (DEN) metabolized by CYP2E1 induces hepatocarcinogenesis in genetically targeted mutant mice: Hepatocyte Ikkß-deletion, oxidative stress, cell death, liver inflammation and growth advantages of Ikkß-deleted hepatocytes augment carcinogenesis in this animal model; tumor suppressor(s) may also be involved. (from Maeda S. et al. CELL 121: , 2005; Koch KS et al., BBRC 380: ,2009)

(from Reference #5)

CARCINOGEN-TARGETED CELLS…which one(s) ? - The cellular target(s) of chemical carcinogens are unknown. - The key questions are whether parenchymal cells (e.g. hepatocytes) or non-parenchymal cells (e.g. stem cells) are the targets? Or both…? - The answers are critical since mechanism and drug therapy studies may be directed towards the wrong cell type(s). - Some investigations suggest that cellular targets may also include non- resident cells that enter tissues via the blood or lymphatic system. - Carcinogens may also alter the functions of cells that do not generate tumors but are required for tumor cell clonal expansion and survival (i.e. tumor progression).

HEPATOCARCINOGENESIS (HCC) LINEAGE MODELS (Diagram is from Koch KS, Leffert HL. Normal liver progenitor cells in culture, in Stem Cells Handbook, ed. S. Sell, Humana Press, Inc., Totowa, NJ, pp , 2004).